News from advanceCOR
Company news and press reports: Here you can find out how we inform the public and what the media is writing about us.
Our press releases
2021
April 2021 – Revacept – an innovative vascular plaster proved in coronary heart disease – Read text as PDF
2020
May 2020 – Further financing round with a consortium of investors completed. – Read text as PDF
February 2020 – Milestone in novel therapy of M. Basedow reached. – Read text as PDF
January 2020 – Phase II study with Revacept for stroke successfully completed. – Read text as PDF
2019
2018
December 2018 – Patient recruitment for Phase II study with Revacept completed. – Read text as PDF
2016
2015
August 2015 – Second financing round closed. MIG AG as main investor. – Read text as PDF
2013
Media reports about us
2021
April 2021 – “Revacept Thrombozyten Hemmung Blutungsrisiko in: gelbe-liste.de – Read text online
April 2021 – „Ein Pflaster gegen Blutgerinnsel“ in: DZG Magazin – Read text online
April 2021 – „Novel Antiplatelet Drug: Hope for Efficacy Without Bleeding?“ in: medscape – Read text online
April 2021 – „Novel Antithrombotic Misses the Mark in PCI“ in: Medpage Today – Read text online
2020
June, 16, 2020 – “advanceCOR closes another financing round of EUR 3.9 million”, in: goingpublic.de – The capital markets portal – Read text online
June, 3, 2020: “Thrombosis: Fresh money for therapy option”, in: transcript – economy technology life – Read text online